Unmet Clinical Need
CAR T cell therapies rely upon a multi-step process involving T cell activation and ex vivo expansion over several weeks. This triggers T cell differentiation (and loss of potency) and requires high labor and material costs.
Proposed Healthcare Solution
A microfluidic device to optimize CAR T cell generation